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Summary
Forty newborn bull calves were assigned to one of four feeding groups. The feeds
either contained lasalocid in milk (M), prestarter (PS), and starter (S); lasalocid in PS and S;
lasalocid in S only; or no lasalocid. Calves were fed M at 8% of birth weight (bw) daily and
offered PS to a maximum of 0.5 lb daily. When 0.5 Ib of PS was consumed in one day the
calves were fed M at 4% of bw daily. They were weaned when they consumed dry feed at
the rate of 1.3% of bw. Daily feed intake and weekly weight gains of calves were evaluated.
Blood serum samples were used to evaluate blood metabolites at wk 4, 8, and 12. We
concluded that lasalocid in M, PS, and S supported greater feed efficiency and allowed earlier
weaning with less animal variation than when lasalocid was delivered in PS and S, only in S,
or not at all.
In troduction
Feeding lasalocid to neonate calves through 12 wk of age has resulted in increased
feed intake and weight gain. The greatest differences were observed during the last six wk.
The lasalocid-fed group received lasalocid in the milk, prestarter, and starter, so it could not
be determined from which part of the diet the lasalocid delivery was having the greatest
effect. .
Lasalocid-fed calves have shown metabolic signs of earlier ruminal development than
control calves. The use of ionophores to encourage early feed consumption and early
weaning may have economic and logistical advantages, because of decreased labor and feed
costs associated with early weaning.
The objective of this study was to determine the most effective method of
administering lasalocid. Three lasalocid treatment groups were used with one negative control
group. A variable weaning program based upon dry feed consumption was used to allow for
differing early feed consumption and differing days to meet requirements for weaning.
Procedures
Forty Holstein bull calves were removed from their dams at 24 hr of age and fed
colostrum until 3 d of age. The calves were then blocked by age, and calves within that block
were randomly assigned to one of four treatment groups. Treatments were feeds with no
lasalocid; feeds with lasalocid in starter (S) only; feeds with lasalocid in prestarter (PS) and
starter; or feeds with lasalocid in milk, prestarter, or starter. The calves in the group
receiving lasalocid in milk (M), prestarter, and starter received untreated prestarter and starter
until 2 wk of age, then lasalocid-treated pres tarter and starter. For the group receiving
lasalocid in milk, it was delivered on days 4 through 14 to provide daily .45 mg/lb of body
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weight daily. Lasalocid concentrations in feed were 80 mg/lb in the prestarter and 13.2 mg/lb
in the starter, with a target consumption of .45 mg/lb of body weight per day. Body weights
were measured weekly.
Milk was fed at 8% of body weight daily divided into two equal feedings and
prestarter was offered beginning on experimental day one. Milk was fed at this rate until the
calf consumed 0.5 Ib of pres tarter daily. The afternoon feeding of milk was discontinued
at that time, and as much starter as the calf would consume daily was mixed with 0.5 Ib
prestarter. When daily dry feed (prestarter plus starter) consumption was 1.3% of body weight
the calf was weaned. Prestarter was discontinued at 5 wk of age. Calves were housed in
individual hutches with straw bedding and given free access to water. Daily feed intake and
weekly weight gains were recorded. Fecal scores were recorded twice daily. Serum samples
were taken at 4, 8, and 12 wk for metabolic evaluation using the SMA- 12 analysis, which
measures a 14 blood metabolites.
Results and Discussion
Table I shows weekly lasalocid intake for each treatment. The lasalocid intake varied
by treatments across time, as was intended by the design of the experiment. The group
receiving lasalocid in M, PS, and S reached the target of .45 mg/lb of body weight by the
second wk, the group receiving lasalocid in PS and S reached the same point by wk 5, and the
group receiving lasalocid in only S reached the target by wk 10. At week 7, calves in all three
treatments were consuming similar amounts of lasalocid.
The group consuming lasalocid in M, PS, and S showed equal or greater ADG (Table
l) than the other three treatments for all 12 weeks. Calves receiving lasalocid in M, PS and
S showed greater feed intake in the first 6 wk. The earlier gains seen in these calves may be
attributed to lasalocid intake near .68 mg/lb during the first 6 wk. All treatment groups
reached the same lasalocid intake from wk 7-12. Figure I shows the feed efficiency in Ib of
feed per Ib of gain for all four treatments. Only dry feed consumption was used in these
calculations. All lasalocid-fed groups had greater feed efficiency than the control group in
wk 3-12. At 4 wk of age the non treated control group had significantly higher fecal scores
than the other three groups, perhaps indicating a beneficial effect of the lasalocid.
The group receiving lasalocid in M, PS, and S reached criterion for IX feeding and
weaning earlier than the other three groups (Figure 2). Blood metabolites reflected the stage
of rumen development of the calves. The group that was weaned earliest showed decreased
glucose and increased urea nitrogen at wk 4. Potassium concentrations at wk 12 were lowest
for the group receiving lasalocid in all three feeds and highest for the control group.
Lasalocid delivered in all three feeds (M, PS and S) appeared to improve feed
efficiency and rumen development and to decrease days to reach criteria for weaning
compared to lasalocid delivery in PS and S or in S only.
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Table I. Daily Lasalocid Intake (mgjlb of body wtjdays) and Cumulative Average Daily
Gain (ADG, Ibjday)
•Lasalocid Delivery
Age, M. PSt S PS. S S only None
wk Lasalocid ADG Lasa10cid ADG Lasa10cid ADG Lasa10cid ADG
1 0.27 0.9 0.10 0.6 0.00 0.8 0 0.7
2 0.44 0.5 0.16 0.4 0.04 0.5 0 0.3
3 0.41 0.6 0.28 0.5 0.03 0.6 0 0.4
4 0.52 0.7 0.37 0.5 0.09 0.6 0 0.5
5 0.60 0.9 0.50 0.6 0.17 0.7 0 0.7
6 0.39 1.1 0.33 0.8 0.33 0.9 0 0.9
7 0.38 1.1 0.38 0.9 0.38 1.1 0 1.1
8 0.42 1.3 0.41 1.1 0.41 1.2 0 1.2
9 0.43 1.3 0.43 1.2 0.42 1.3 0 1.2
10 0.42 1.4 0.44 1.2 0.44 1.3 0 1.4
11 0.40 1.5 0.43 1.3 0.44 1.5 0 1.4
12 0.42 1.6 0.44 1.5 0.47 1.6 0 1.5
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Figure I. Feed Efficiency for Four Treatment Groups.
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Figure 2. Days to Reach Criterion for A.M. only Feeding and Days to Weaning for Four
Treatment Groups (M=Milk, PS=prestarter, S=starter).
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